effects [qlco]
Estrogen [horm, phsu, strd]
Estrogen [horm, phsu, strd]
regimens [inpr]
Heart disease [dsyn]
risk factors [qnco]
postmenopausal [tmco]
Women [popg]
postmenopausal [tmco]
Estrogen [horm, phsu, strd]
Progestin [horm, phsu, strd]
Intervention Trial [resa]
Objective [inpr]
placebo [topp]
Estrogen [horm, phsu, strd]
Estrogen [horm, phsu, strd]
Progestin [horm, phsu, strd]
regimens [inpr]
Select [acty]
heart disease risk [fndg]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Design [acty]
randomized [resa]
DOUBLE BLIND [resa]
placebo-controlled [resa]
Trial [resa]
participants [popg]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Aged [orga]
Known [qlco]
Contraindication [qlco]
Hormone Therapy [topp]
intervention [hlca]
participants [popg]
Assigned [ftcn]
Equal [qlco]
Following [tmco]
Group [idcn]
placebo [topp]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
mg/d [qnco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
mg/d [qnco]
Cyclic [tmco]
medroxyprogesterone acetate [horm, phsu, strd]
mg/d [qnco]
MO [idcn]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
mg/d [qnco]
Consecutive [qlco]
medroxyprogesterone acetate [horm, phsu, strd]
2 5 [qnco]
mg/d [qnco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
mg/d [qnco]
Cyclic [tmco]
progesterone, micronized [horm, phsu, strd]
mg/d [qnco]
MO [idcn]
Primary Endpoint [irda]
Chosen [acty]
Represent [acty]
Biological [bmod]
System [ftcn]
Cardiovascular disease [dsyn]
High Density Lipoprotein Cholesterol [bacs, lipd]
Systolic blood pressure [clna]
Serum insulin [lbpr]
Fibrinogen [aapp, bacs, phsu]
Presented [idcn]
Intention [menp]
P-Value [qnco]
Primary Endpoint [irda]
Adjusted [ftcn]
Multiple [qnco]
Comparison [acty]
Confidence Intervals [qnco]
Estimated [qnco]
effects [qlco]
Calculated [ftcn]
Adjustment [inbe]
High Density Lipoprotein Cholesterol [bacs, lipd]
segregation [socb]
Treatment Regimen [topp]
Statistically [ocdi]
Group [idcn]
placebo [topp]
Decrease [qlco]
mmol/dL [qnco]
mg% [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
regimens [inpr]
increases [ftcn]
mmol/L [qnco]
mg dl [qnco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Cyclic [tmco]
progesterone, micronized [horm, phsu, strd]
mmol/dL [qnco]
mg% [qnco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Alone [qnco]
mmol/dL [qnco]
mg% [qnco]
Active Treatment [topp]
Decreased [qnco]
Low Density Lipoprotein Cholesterol [bacs, strd]
MMOLE [qnco]
mg dl [qnco]
Increased [qnco]
Triglyceride [bacs, lipd]
mmol/L [qnco]
mg dl [qnco]
Compared [acty]
placebo [topp]
placebo [topp]
Fibrinogen [aapp, bacs, phsu]
Active Treatment [topp]
g l [qnco]
Compared [acty]
g l [qnco]
Active Treatment [topp]
Not significant [fndg]
Systolic blood pressure [clna]
Increased [qnco]
insulin levels [lbpr]
Decreased [qnco]
Trial [resa]
treatment [ftcn]
Assignment [ftcn]
Compared [acty]
Active Treatment [topp]
Estrogen [horm, phsu, strd]
Increased [qnco]
Atypical hyperplasia [patf]
Hysterectomy [topp]
Adverse Effect [fndg]
treatment [ftcn]
Assignment [ftcn]
Hysterectomy [topp]
Status [qlco]
Conclusions [idcn]
Estrogen [horm, phsu, strd]
Alone [qnco]
Combination [qlco]
Progestin [horm, phsu, strd]
Lipoproteins [aapp, bacs]
fibrinogen levels [lbpr]
effects [qlco]
Insulin [aapp, horm, phsu]
Blood Pressure [orgf]
Estrogen [horm, phsu, strd]
Optimal [qlco]
Regimen [topp]
Elevation [topp]
High Density Lipoprotein Cholesterol [bacs, lipd]
Endometrial Hyperplasia [dsyn]
restrict [ftcn]
Women [popg]
Uterus [bpoc]
Women [popg]
Uterus [bpoc]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Cyclic [tmco]
progesterone, micronized [horm, phsu, strd]
Favorable [qlco]
High Density Lipoprotein Cholesterol [bacs, lipd]
Excess [qlco]
Endometrial Hyperplasia [dsyn]
